095700.KQ
Genexine, Inc.
KOE · Healthcare · Biotechnology · KR
KRW 2,835.00
+1.43%Latest reported
- Last report date
- Aug 18, 2026
- EPS actual
- -KRW 578
- EPS estimate
- KRW 158
- Revenue actual
- KRW 972.2M
- Revenue estimate
- KRW 972.2M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 0
- EPS misses (12Q)
- 1
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- -466.0%
- Revenue beats (12Q)
- 0
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 18, 2026 | KRW 158 | -KRW 578 | Miss -465.99% | KRW 972.2M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Aug 18, 2026